MENU
+Compare
BHVN
Stock ticker: NYSE
AS OF
Nov 21 closing price
Price
$9.69
Change
+$0.06 (+0.62%)
Capitalization
1.29B

BHVN Biohaven Ltd Forecast, Technical & Fundamental Analysis

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

BHVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BHVN with price predictions
Nov 21, 2025

BHVN in downward trend: 10-day moving average broke below 50-day moving average on November 06, 2025

The 10-day moving average for BHVN crossed bearishly below the 50-day moving average on November 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

BHVN moved below its 50-day moving average on November 03, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHVN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BHVN's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 19, 2025. You may want to consider a long position or call options on BHVN as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BHVN just turned positive on November 21, 2025. Looking at past instances where BHVN's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BHVN advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

BHVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 256 cases where BHVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.124) is normal, around the industry mean (27.249). P/E Ratio (0.000) is within average values for comparable stocks, (51.596). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (320.418).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BHVN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
BHVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BHVN is expected to report earnings to fall 16.46% to -137 cents per share on March 19

Biohaven Ltd BHVN Stock Earnings Reports
Q4'25
Est.
$-1.37
Q3'25
Beat
by $0.24
Q2'25
Beat
by $0.31
Q1'25
Missed
by $0.47
Q4'24
Missed
by $0.11
The last earnings report on November 10 showed earnings per share of -163 cents, beating the estimate of -187 cents. With 3.38M shares outstanding, the current market capitalization sits at 1.29B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
215 Church Street
Phone
+1 203 404-0410
Employees
239
Web
https://www.biohavenpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLRRX9.690.10
+1.04%
LDR Real Estate Value Opportunity Instl
NWAUX14.260.10
+0.71%
Nationwide GQG US Quality Eq A
TTMIX161.841.05
+0.65%
T. Rowe Price Comm & Tech I
EEMCX14.46-0.03
-0.21%
Columbia Emerging Markets C
RDWGX13.48-0.06
-0.44%
American Funds Dvlpg Wld Gr&Inc R6

BHVN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BHVN has been loosely correlated with SYRE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BHVN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHVN
1D Price
Change %
BHVN100%
+0.62%
SYRE - BHVN
48%
Loosely correlated
+3.37%
CGON - BHVN
46%
Loosely correlated
+4.25%
LENZ - BHVN
44%
Loosely correlated
+6.64%
IDYA - BHVN
44%
Loosely correlated
+2.50%
ELVN - BHVN
43%
Loosely correlated
+2.26%
More